Malignant Neoplasms
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
CTAGE1 protein, human
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Pancreatic Adenocarcinoma Locally Advanced
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Small Cell Lung Cancer
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Relapsed Cancer
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Advanced Non Small Cell Lung Cancer (NSCLC)
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Malignant Neoplasms
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Metastatic Breast Cancer
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
stage 4 Pancreatic adenocarcinoma
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Non-Small Cell Lung Carcinoma
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Mesotheliomas
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Hodgkin Disease
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
previous adjuvant anthracycline-containg therapy
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Advanced Ovarian Cancer
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
disease progression after chemotherapy
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Pharmacotherapy
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Urinary Bladder
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Cervical Cancer
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous
Head and Neck Carcinoma
100.0 mg/mL, , 200.0 mg/mL, 38.0 mg/mL, 200.0 mg, 1000.0 mg, 2000.0 mg, 10.0 mg/mL, 40.0 mg/mL
Powder, Injection, powder, lyophilized, for solution, Solution - Intravenous, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Injection - Intravenous, Solution, Injection, solution, , Injection, solution - Intravenous, Powder, for solution - Intravenous, Powder, for solution, Injection, Powder - Intravenous